CPChendong Pan

Chendong Pan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chendong Pan has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • David H. Thompson

    Department of Chemistry, Multidisciplinary Cancer Research Facility, Purdue University, 1203 W. State Street, West Lafayette, Indiana 47907, United States

    1 shared publication
  • Dena Almeida

    Microscopy and Image Analysis Core, Weill Cornell Medical College, Cornell University 5 , New York City, NY

    1 shared publication
  • Enrique Rodriguez-Boulan

    Department of Ophthalmology, Weill Cornell Medicine, Margaret Dyson Vision Research Institute, New York, NY 10065

    1 shared publication
  • Guillermo L. Lehmann

    Department of Ophthalmology, Weill Cornell Medicine, Margaret Dyson Vision Research Institute, New York, NY 10065

    1 shared publication
  • Ignacio Benedicto

    Department of Ophthalmology, Weill Cornell Medicine, Margaret Dyson Vision Research Institute, New York, NY 10065

    1 shared publication
  • Kalpita Banerjee

    Weil Cornell Medical College, Ophthalmology Department, Dyson Research Institute, 1300 York Avenue, New York, New York 10065, United States

    1 shared publication

Latest Publications

  • Lipofuscin causes atypical necroptosis through lysosomal membrane permeabilization

    by Chendong Pan, Kalpita Banerjee, Guillermo L. Lehmann, Dena Almeida, Katherine A. Hajjar, Ignacio Benedicto, Zhichun Jiang, Roxana A. Radu, David H. Thompson, Enrique Rodriguez-Boulan, et al.

    Significance: Retinal lipofuscin causes retinal pigment epithelium cell death in Stargardt and potentially dry–Age-Related Macular Degeneration (AMD). The current dogma is that lipofuscin’s cytotoxicity results from the light-triggered decomposition of its lipid-bisretinoids leading to apoptosis. However, antiapoptotic antioxidants or light-blocking lenses are not effective to stop degeneration in Stargardt and most AMD patients. Here, we show that lipofuscin forms aggregates in lysosomes, which trigger lysosomal membrane permeabilization and subsequent atypical necroptosis. We provide evidence that necrosulfonamide, necrostatin-7, and arimoclomol can effectively control this lethal cascade.